TP53 and brain neoplasm: We discovered insights into the existence of amyloid-like mutant p53 species in brain tumor cells presenting a chemoresistance gain-of-function phenotype and the distribution of mutant p53 multimers larger than the active tetrameric form of p53 in living cells.